These observations suggest that the mechanisms for the insulin therapy-induced obesity in diabetic patients might be different from those for the association between obesity and hyperinsulinemia as a compensatory indictor of insulin resistance in the general population. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.